2019 annual results: Korian benefits from the success of its diversified and local growth mode

> Strong growth momentum: 8.3% revenue growth of which 3.8% organic
- Acceleration of the diversification in medical and home care: serving 470,000 clients in 2019, x2 since 2016,
- Expansion of the portfolio by 4,528 beds over the period, totalling 82,675 beds end 2019

> Operating margin (EBITDA) improved by +50 bps to 14.8%
- Increased staff intensity compensated by efficient cost structure
- Positive impact from the diversification of activities and Asset Smart strategy: Real estate ownership reaching 22%

> Strong cash generation of €231m

> €353m of targeted investments to support the Group’s buy and build strategy
- Targeted expansion of geographical footprint with entry into 2 new countries: Spain 2,000 beds in 2019 and Netherlands with a pipeline of 1,300 beds by 2021
- Investment in increased medical reach, development in home care and innovative digital solutions

> Value of real estate portfolio reaching over €2bn (x2 since 2016)

> Solid financial structure in a context of acceleration of the Group’s development: Stable Adjusted EBITDA /debt ratio x3.1 and Loan-to-value 52%

> In caring hands corporate project: Korian pioneers 15 specific ESG commitments to create a positive impact for clients, staff and stakeholders

> Acceleration in 2020 and strong confidence in 2021 guidance
- 2020: c. 9% of growth in revenue and an EBITDA margin at least 15%
- 2021 : above €4.2bn revenue and 15.5% EBITDA margin, c. €300m operating FCF

> Proposed dividend up by 10% to €0.66, with an option for payment in new shares